All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
ARWR total return snapshot: ARWR returned +363.20% over the past year and +17.35% YTD, with dividends reinvested. Since Dec. 16, 1993, ARWR is down −97.34% in nominal total return, or −10.57%/yr.
| Thu 1993-12-16💬 to Fri 2026-05-29 |
YTD
Return |
1 Year
Return |
||||
|---|---|---|---|---|---|---|
| ARWR × |
+17.35%
2026-05-29 |
+363.20%
2026-05-29 |
||||
| Arrowhead Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Thu 1993-12-16💬 to Fri 2026-05-29 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| ARWR × |
−97.34%
−10.57%/yr |
−3.15%/yr
(R2=0.043) |
||||
| Arrowhead Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Thu 1993-12-16💬 to Fri 2026-05-29 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| ARWR × |
$10,000.00
1993-12-16 |
$266.36
2026-05-29 |
||||
| Arrowhead Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Year | ARWR |
|---|---|
| 2026 (YTD) | +17.35% |
| 2025 | +253.14% |
| 2024 | −38.56% |
| 2023 | −24.56% |
| 2022 | −38.82% |
| 2021 | −13.59% |
| 2020 | +20.97% |
| 2019 | +410.71% |
| 2018 | +237.50% |
| 2017 | +137.42% |
| 2016 | −74.80% |
| 2015 | −16.67% |
| 2014 | −31.98% |
| 2013 | +407.01% |
| 2012 | −48.93% |
| 2011 | −53.18% |
| 2010 | +68.87% |
| 2009 | −42.39% |
| 2008 | −75.66% |
| 2007 | −13.70% |
| 2006 | +3.06% |
| 2005 | −1.62% |
| 2004 | +232.31% |
| 2003 | +233.33% |
| 2002 | −60.00% |
| 2001 | −76.00% |
| 2000 | +25.00% |
| 1999 | −37.50% |
| 1998 | +60.00% |
| 1997 | −68.00% |
| 1996 | −37.50% |
| 1995 | −80.00% |
| 1994 | −54.55% |
| 1993 | −38.89% |
| Thu 1993-12-16💬 to Fri 2026-05-29 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| ARWR × | −97.34% |
−99.96%
2016-12-16 |
||||
| Arrowhead Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Period ending Fri 2026-05-29 |
1
Year |
2
Years |
3
Years |
5
Years |
10
Years |
|
|---|---|---|---|---|---|---|
| ARWR × | +363.20% |
+240.66% +84.65%/yr |
+131.88% +32.25%/yr |
+7.31% +1.42%/yr |
+1,222.75% +29.45%/yr |
|
| Arrowhead Pharmaceuticals Inc NASDAQ Common Stock | ||||||
